EBS:NYSE
Emergent Biosolutions Inc
USD 6.33
arrow_downward
-0.63%(-0.040) 1H
USD 6.31
arrow_downward
-0.32% (-0.020)bedtimeSelepas waktu pejabat
Ditutup: 2 Okt, 4:00:02 PTG GMT-4 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk EBS...
Buka
USD 6.41
Tinggi
USD 6.41
Rendah
USD 6.24
Permodalan Pasaran
324.56J
Purata volum
1.15J
Volum
614.59K
tgi 52 mgu
USD 14.06
rdh 52 mgu
USD 4.36
EPS
-USD 3.51
Beta
2.28
Syer tertunggak
51.27J
Bilangan pekerja
900
Buka
USD 6.41
Tinggi
USD 6.41
Rendah
USD 6.24
Permodalan Pasaran
324.56J
Purata volum
1.15J
Volum
614.59K
tgi 52 mgu
USD 14.06
rdh 52 mgu
USD 4.36
EPS
-USD 3.51
Beta
2.28
Syer tertunggak
51.27J
Bilangan pekerja
900
Cerita berita
Daripada sumber web dan rakan kongsi berita
Invezz
·
1 hari lalu
Dow naik 260 mata selepas data pekerjaan lemah mengangkat saham AS
Seeking Alpha
·
1 jam lalu
AI spending to drive another strong S&P 500 earnings season, Goldman Sachs says
Simply Wall Street
·
1 jam lalu
One MoneyHero Limited (NASDAQ:MNY) Analyst Is Reducing Their Forecasts For This Year
AD HOC NEWS
·
18 minit lalu
GTIM stock reports stronger fiscal third quarter earnings
Profil
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
Perihal Emergent Biosolutions Inc
CEORobert G. Kramer Sr. | Joseph C. Papa
Pekerja900
Diasaskan5 Sep 1998
Ibu pejabatRockville, Maryland, Amerika Syarikat
Sektor-
Laman webemergentbiosolutions.com